Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, September 27, 2004

Pregnancy is a risk factor for restless legs syndrome

St. Paul, Minn. -

Pregnant women are at higher risk for the occurrence or worsening of restless legs syndrome (RLS), a movement disorder that affects up to 10 percent of the general population, according to a study reported in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology. Researchers in Milan, Italy, recently concluded a large and detailed epidemiological study on RLS during pregnancy and six months post-partum that demonstrates at least one in four pregnant women experience RLS. RLS is characterized by an urge to move the legs, generally accompanied by unpleasant numbness, tingling, or burning sensations; an increase in symptoms during rest and a partial, temporary relief from symptoms through activity; and a worsening of symptoms in the evening or at night. Symptoms tend to progress with age. The association between RLS and pregnancy was noted first in 1940, and confirmed later by a few epidemiological investigations. “While several attempts have been made to study the connection between pregnancy and RLS, ours is the first epidemiological study to use the four standard International RLS committee diagnostic criteria,” noted Mauro Manconi, MD, of the Sleep Disorders Center at Vita-Salute University, Milan. A total of 606 women, admitted to the Department of Gynecology and Obstetrics of Ferrara University between February and June 2002, were included in the study. Two neurologists certified in sleep medicine interviewed the women within two days of delivery, and those affected by RLS were interviewed again at the end of the first, third, and sixth month after delivery. The initial interview included demographic data, personal and family medical history, course of pregnancy, physical measurements of mother and newborn, iron and folate therapy, sleep habits, and presence of sleep disorders. A detailed description of RLS symptoms, if present during and before pregnancy, was also evaluated. A woman was considered affected by RLS if she met all four International RLS Study Group criteria. Of the 606 women in the study, 161 (26.6 percent) reported the occurrence of RLS, 101 of whom reported experiencing RLS for the first time. One-fourth of the women experienced RLS symptoms at least once a week, and 15 percent at least three times a week. The appearance or worsening of RLS symptoms was generally around the sixth month, reaching a peak at the seventh and eighth months of pregnancy. RLS prevalence dramatically decreased around the time of delivery, ranging between five and six percent at six months post-partum. RLS symptoms had a significant impact on sleep, with affected women reporting a reduced total sleep time, longer sleep latency, and more frequent insomnia and excessive daytime sleepiness compared to non-affected women. “The pregnant women most affected by RLS were older, had lower values of iron storage indicators, a higher prevalence of insomnia, and snored more than the unaffected group,” commented Manconi. However he also said, “Our results on a significant difference in iron storage indicators support a hypothesis that a relative iron deficit could play a role in this form of RLS, though the rapid improvement of RLS symptoms after delivery give more power to a hormonal rather than iron-related hypothesis.” Even if the real cause of the association between RLS and pregnancy remains unclear, this study is the first to show a significant correlation between low iron indicators values and the risk to develop RLS. Further investigations are needed to evaluate the role of hormonal state and of personal genetic background predisposition in the cause of this temporary state of RLS. This research was supported by the Italian Ministry of University and Research and by a previous grant from the International Restless Legs Syndrome Study Group.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life®, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.

DISCOVER MORE


Subscribe to our email newsletter

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.

For More Information*

Email media@aan.com

*While content of the American Academy of Neurology (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver website, Brain & Life®.